The MAF-transcription factor regulates the expression of proteins including PTHrP, involved in the vicious cycle of bone destruction, and MAF amplification within primary breast cancer tumours significantly correlates with bone metastasis risk (HR = 14.5, CI = 6.4 to 32.9, p < 0.001) [18,19,35]. Here, MAF is linked to breast carcinoma.